Chimeric Therapeutics

Provider of CAR T cell therapies for solid tumors

placeCarlton, Victoria, Australia calendar_todayFounded 2020 groups19 employees language chimerictherapeutics.com

Social engagement

Social engagement: 6.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; 1 has since exited.

Investor typeCountShare
Private equity1100%

Recent activity

2 Jul 2026
Recognition
31 May 2026
Milestone
regulatory
13 May 2026
Event
ASCGT
Coming soon